Does the addition of serum antimüllerian hormone concentrations to the Framingham Risk Score and Pooled Cohort Equations improve the prediction of cardiovascular disease?. Issue 4 (30th April 2023)

• Record Type: Journal Article
• Authors: Amiri, Mina; Ahmadi, Narjes; Hadaegh, Farzad; Mousavi, Maryam; Azizi, Fereidoun; Ramezani Tehrani, Fahimeh
• Is Part Of: Menopause. Volume 30:Issue 4(2023)
• Page Start: 406
• Page End: 413
• Publication Date: 2023-04-30
• Subjects: Antimüllerian -- Cardiovascular disease -- Risk assessment -- Risk factor; Menopause -- Periodicals; 618.175005
• DOI: 10.1097/GME.0000000000002145
• Languages: English
• ISSNs: 1072-3714

Abstract

Abstract : The present study revealed that the addition of serum antimüllerian hormone concentrations to Framingham Risk Score and Pooled Cohort Equations could potentially improve the risk prediction of cardiovascular disease. Abstract: Objective: The current study aimed to examine the added value of serum antimüllerian hormone (AMH) concentration to the Framingham Risk Score (FRS) and Pooled Cohort Equations (PCE) in predicting the risk of cardiovascular disease (CVD) in women of reproductive age. Methods: Women 30 years and older were considered eligible for this population-based prospective study. The univariate and multivariate Cox proportional hazard models were used to evaluate the association between the serum concentrations of AMH and the risk of CVD. Results: In the enhanced model, which integrated AMH into FRS and PCE and was adjusted for family history of premature CVD, AMH showed a significant association with the risk of CVD during a 19-year follow-up of 800 women (hazard ratio, 0.77 [95% CI, 0.60-0.99] and hazard ratio, 0.64 [95% CI, 0.48-0.84], respectively). According to the likelihood-ratio test, the addition of AMH measurements to FRS and PCE could significantly improve the risk prediction of CVD ( P = 0.02 and P < 0.001, respectively); however, the integration of this biomarker did not improve the classification of risk categories. Conclusions: The present findings revealed that the addition of serum AMH concentrations to FRS and PCE could potentially improve the risk prediction of CVD.